Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan

American Journal of Health-System Pharmacy

Volumn 64, Issue 10, 2007, Pages 1054-1061

  Camargo Jr , Carlos A ^a   Ramachandran, Sulabha ^b   Ryskina, Kira L ^c   Lewis, Barbara Edelman ^b   Legorreta, Antonio P ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ASTRAZENECA   (United Kingdom)

^c Health Benchmarks Inc   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aerosols; Asthma; Budesonide; Compliance; Health benefit programs; Patients; Pediatrics; Steroids, cortico

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ARTICLE; ASTHMA; BILLING AND CLAIMS; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 34249008161     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060256     Document Type: Article

References (38)

1. Dey AN, Schiller JS, Tai DA. Summary health statistics for U.S. children: National Health Interview Survey, 2002. Vital Health Stat. 2004; 10:1-78.
2. Mannino DM, Homa DM, Akinbami LJ et al. Surveillance for asthma - United States, 1980-1999. MMWR Surveill Summ. 2002; 51:1-13.
3. Mannino DM, Homa DM, Pertowski CA et al. Surveillance for asthma - United States, 1960-1995. MMWR Surveill Summ. 1998; 47:1-27.
4. Buescher PA, Jones-Vessey K. Using Medicaid data to estimate state- and county-level prevalence of asthma among low-income children. Matern Child Health J. 1999; 3:211-6.
5. Halfon N, Newacheck PW. Childhood asthma and poverty: differential impacts and utilization of health services. Pediatrics. 1993; 91:56-61.
6. Ray NF, Thamer M, Fadillioglu B et al. Race, income, urbanicity, and asthma hospitalizations in California. Chest. 1998; 113:1277-84.
7. David C. Preventive therapy for asthmatic children under Florida Medicaid: changes during the 1990s. J Asthma. 2004; 41:655-61.
8. Cooper WO, Hickson GB. Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or a hospitalization for asthma. Arch Pediatr Adolesc Med. 2001; 155:1111-5.
9. Piecoro LT, Potoski M, Talbert JC et al. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res. 2001; 36:357-71.
10. Fredrickson DD, Molgaard CA, Dismuke SE et al. Understanding frequent emergency room use by Medicaid-insured children with asthma: a combined quantitative and qualitative study. J Am Board Fam Pract. 2004; 17:96-100.
11. Ferris TG, Crain EF, Oken E et al. Insurance and quality of care for children with acute asthma. Ambul Pediatr. 2001; 1:267-74.
12. Finkelstein JA, Barton MB, Donahue JG et al. Comparing asthma care for Medicaid and non-Medicaid children in a health maintenance organization. Arch Pediatr Adolesc Med. 2000; 154:563-8.
13. Bratton SL, Roberts JS, Watson RS et al. Acute severe asthma: outcome and Medicaid insurance. Pediatr Crit Care Med. 2002; 3:234-8.
14. Griswold SK, Nordstrom CR, Clark S et al. Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department? Chest. 2005; 127:1579-86.
15. To T, Dick P, Feldman W. A cohort study on childhood asthma admissions and readmissions. Pediatrics. 1996; 98(2 pt. 1):191-5.
16. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: NIH/National Heart, Lung, and Blood Institute; 1997. Publication 97-4051.
17. Adams RJ, Fuhlbrigge A, Finkelstein JA et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001; 107:706-11.
18. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in prevalence of asthma. J Allergy Clin Immunol. 1996; 97:742-8.
19. Blais L, Ernst P, Boivin JF et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med. 1998; 158:126-32.
20. Smith MJ, Rascati KL, McWilliams BC. Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Ann Allergy Asthma Immunol. 2004; 92:40-6.
21. Buchner DA, Carlson AM, Stempel DA. Patterns of anti-inflammatory therapy in the post-guidelines era: a retrospective claims analysis of managed care members. Am J Manag Care. 1997; 3:87-93.
22. Jatulis DE, Meng YY, Elashoff M et al. Preventive pharmacologic therapy among asthmatics: five years after publication of guidelines. Ann Allergy Asthma Immunol. 1998; 81:82-8.
23. Legorreta AP, Christian-Herman J, O'Connor RD et al. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience. Arch Intern Med. 1998; 158:457-64.
24. Meng YY, Leung KM, Berkbigler D et al. Compliance with US asthma management guidelines and specialty care: a regional variation or national concern? J Eval Clin Pract. 1999; 5:213-21.
25. Adams RJ, Fuhlbrigge A, Finkelstein JA et al. Use of inhaled anti-inflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001; 155:501-7.
26. Lozano P, Finkelstein JA, Hecht J et al. Asthma medication use and disease burden in children in a primary care population. Arch Pediatr Adolesc Med. 2003; 157:81-8.
27. Leickly FE, Wade SL, Crain E et al. Self-reported adherence, management behavior, and barriers to care after an emergency department visit by inner city children with asthma. Pediatrics. 1998; 101:E8.
28. Shapiro G, Mendelson L, Kraemer MJ et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol. 1998; 102:789-96.
29. Baker JW, Mellon M, Wald J et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999; 103:414-21.
30. Kemp JP, Skoner DP, Szefler SJ et al. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol. 1999; 83:231-9.
31. Leflein JG, Szefler SJ, Murphy KR et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics. 2002; 109:866-72.
32. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50:105-16.
33. Chipps BE, Schnepp CM, Briscoe M. Budesonide inhalation suspension reduces the need for emergency intervention in pediatric asthma: a named-patient case series. J Asthma. 2003; 40:895-900.
34. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-97.
35. Fuhlbrigge AL, Adams RJ, Guilbert TW et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program guidelines. Am J Respir Crit Care Med. 2002; 166:1044-9.
36. 2-agonists alone. J Allergy Clin Immunol. 2003; 112:1088-94.
37. Roos LL Jr, Nicol JP, Cageorge SM. Using administrative data for longitudinal research: comparisons with primary data collection. J Chronic Dis. 1987; 40:41-9.
38. Yoos HL, Kitzman H, Halterman JS et al. Treatment regimens and health care utilization in children with persistent asthma symptoms. J Asthma. 2006; 43:385-91.